![Sean Kendall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sean Kendall
Direttore/Membro del Consiglio presso Airna, Inc.
Profilo
Sean Kendall is currently a Director at Protillion Biosciences, Inc. and Airna, Inc. He is also a Partner at ARCH Venture Partners LLC since 2015.
Previously, he worked as a Principal at Cobalt Technologies, Inc. and LS Dissolution, Inc. He also held the position of Associate at LS Dissolution, Inc. from 2007 to 2012.
Mr. Kendall completed his undergraduate and graduate studies at Stanford University and holds an MBA from The University of Chicago.
Posizioni attive di Sean Kendall
Società | Posizione | Inizio |
---|---|---|
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investitore di Private Equity | 01/01/2021 |
Protillion Biosciences, Inc.
![]() Protillion Biosciences, Inc. BiotechnologyHealth Technology Protillion Biosciences, Inc. is a company based in Burlingame, CA that was founded in 2019 by Will Greenleaf, David R. Walt, and Curtis Layton. The company specializes in commercializing disruptive technology for therapeutic antibody and binder discovery. The company's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run, enabling the identification of better antibody candidates on an exponentially faster timeline compared to current state-of-the-art antibody discovery and optimization techniques that may take months of laborious laboratory procedures executed by highly-skilled practitioners. Curtis Layton has been the CEO since 2019. | Direttore/Membro del Consiglio | - |
Airna, Inc.
![]() Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sean Kendall
Società | Posizione | Fine |
---|---|---|
LS Dissolution, Inc.
![]() LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2012 |
Cobalt Technologies, Inc.
![]() Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - |
LS Dissolution, Inc.
![]() LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Sean Kendall
The University of Chicago | Masters Business Admin |
Stanford University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
LS Dissolution, Inc.
![]() LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Process Industries |
Cobalt Technologies, Inc.
![]() Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Process Industries |
Protillion Biosciences, Inc.
![]() Protillion Biosciences, Inc. BiotechnologyHealth Technology Protillion Biosciences, Inc. is a company based in Burlingame, CA that was founded in 2019 by Will Greenleaf, David R. Walt, and Curtis Layton. The company specializes in commercializing disruptive technology for therapeutic antibody and binder discovery. The company's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run, enabling the identification of better antibody candidates on an exponentially faster timeline compared to current state-of-the-art antibody discovery and optimization techniques that may take months of laborious laboratory procedures executed by highly-skilled practitioners. Curtis Layton has been the CEO since 2019. | Health Technology |
Airna, Inc.
![]() Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum. | Commercial Services |
- Borsa valori
- Insiders
- Sean Kendall